Evidence map›Paper›PMID 33335836›Full record

ArticleMolecular genetics and metabolism reports2020

Patients with Gaucher disease display systemic oxidative stress dependent on therapy status.

Reena V Kartha, Marcia R Terluk, Roland Brown, Abigail Travis, Usha R Mishra, Kyle Rudser, Heather Lau, Jeanine R Jarnes, James C Cloyd, Neal J Weinreb

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular genetics and metabolism reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06211478 (Role of Vitamin E as an Adjuvant Therapy for Patients With Gaucher Disease Under Enzyme Replacement Therapy in Relation to Oxidative Stress), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06211478 phase3completednot on this mapstarted 2023, after this paper: background citation

Role of Vitamin E as an Adjuvant Therapy for Patients With Gaucher Disease Under Enzyme Replacement Therapy in Relation to Oxidative Stress

TypeinterventionalSponsorAin Shams UniversityRan2023 to 2023Enrolled40ConditionsGaucher DiseaseArmsVitamin E
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Glucosylsphingosine (Lyso-GbInternational journal of molecular sciences · 2022
    Article
  12. The Impact of Oxidative Stress on Pediatrics Syndromes.Antioxidants (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Gaucher disease - more than just a rare lipid storage disease.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Reena V KarthaCenter for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
Marcia R TerlukCenter for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
Roland BrownDivision of Biostatistics, University of Minnesota, Minneapolis, MN 55455, United States.
Abigail TravisCenter for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
Usha R MishraCenter for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
Kyle RudserDivision of Biostatistics, University of Minnesota, Minneapolis, MN 55455, United States.
Heather LauDivision of Neurogenetics, Department of Neurology, New York University, New York, NY, United States.
Jeanine R JarnesDepartment of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
James C CloydCenter for Orphan Drug Research, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States.
Neal J WeinrebDepartment of Human Genetics and Medicine (Hematology), Leonard Miller School of Medicine of University of Miami, Miami, FL, United States.
University of Minnesota · USFairview Health Services · USNew York University · USUniversity of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gaucher disease is an autosomal recessive metabolic disorder caused by mutations in

Indexed as

ACE, angiotensin converting enzymeAntioxidantsCHITO, chitotriosidaseCNS, central nervous systemERT, enzyme replacement therapyGaucher diseaseGCase, glucocerebrosidaseGD1, Type 1 Gaucher diseaseGD2, Type 2 Gaucher diseaseGD3, Type 3 Gaucher diseaseGD, Gaucher diseaseGlutathioneGPG, Glycine-Proline-GlutamateGPx, glutathione peroxidaseGSH, glutathioneGSSG, inactive, oxidized form of glutathioneHPLC, high performance liquid chromatographyLC-MS/MS, liquid chromatography-tandem mass spectrometryLipid peroxidationLyso-GL1, glucosylsphingosineMDA, malondialdehydeNYU, New York UniversityOxidative stressRBC, red blood cellROS, reactive oxygen speciesSOD, superoxide dismutaseSRT, substrate reduction therapyTAC, total antioxidant capacityTBARS, thiobarbituric acid reactive substancesTRAP, tartrate resistant acid phosphataseUMN, University of Minnesota

Identifiers

PMID33335836
PMCPMC7733024
OpenAlexW3111842185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.